BCL11A targeting program (Monte Rosa Therapeutics)

N/A

Report date: 2025/01/26 18:26:20
NME

Base Information

Drug NameBCL11A targeting program (Monte Rosa Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionB-cell lymphoma/leukemia 11A degraders
TargetsB-cell lymphoma/leukemia 11A
Therapy Area/IndicationsSickle Cell Crisisbeta-Thalassemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMonte Rosa Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMonte Rosa Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSickle Cell Crisisbeta-Thalassemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A